logo

Applied Dna Sciences Inc (APDN)



Trade APDN now with
  Date
  Headline
11/25/2019 1:32:55 PM Applied DNA Sciences Regains Compliance With Nasdaq Listing Standards
11/13/2019 9:25:36 AM Applied DNA Sciences Reports Pricing Of Upsized $12.0 Mln Public Offering
9/19/2019 4:08:10 AM LineaRx, Takis/Evvivax Anti-Cancer Vaccine Candidates Show Tumor Reduction
8/8/2019 5:52:32 AM LineaRx Acquires Assets And Intellectual Property Of Vitatex
7/2/2019 9:31:20 AM Applied DNA Sciences Signs 5-year Agreement With Montblanc-Simplo GMBH
4/12/2019 3:13:31 AM Applied DNA Signs MoU With Stahl To Bring CertainT Platform To Manufacturing Supply Chains
3/29/2019 5:35:29 AM Applied DNA Announces Cannabis Licensing And Cooperation Agreement With Theracann International
2/12/2019 5:16:36 AM Applied DNA Signs Term Sheet With TheraCann International For License Of CertainT Platform In Legal Cannabis And Hemp
1/29/2019 5:09:21 AM Applied DNA Appoints Stephen Birkhold To The Strategic Advisory Board
1/28/2019 5:02:56 AM Applied DNA Signs MOU With Tex-Ray Industrial To Introduce CertainT Authentication Platform To Global Textile Brands
12/27/2018 4:08:01 PM Applied DNA Announces Closing Of $2.75 Mln Public Offering Of Common Stock And Warrants
12/21/2018 8:34:05 AM Applied DNA Announces Pricing Of $2.75 Mln Offering Of Common Stock And Warrants
12/13/2018 7:06:24 AM Applied DNA Sciences Q4 Revenue Increases 4% To $1.2 Mln
11/19/2018 9:15:47 AM Applied DNA, Eurofins BLC Sign Collaboration To Support Commercial Implementation Of Leather Traceability System
10/16/2018 5:09:57 AM LineaRx Licenses CAR T Drug Candidate; Begins Pre-Clinical Development Of Plasmid-Free CAR T Manufacturing Platform
10/4/2018 5:02:16 AM Applied DNA Appoints Wayne Buchen VP Of Strategic Sales For Textile Vertical
10/1/2018 5:02:57 AM Applied DNA Sciences Says LineaRx Secures New RNA Therapeutics Customers For Contract Research Services
9/20/2018 5:04:37 AM LineaRx Signs Joint Development Agreement With Takis S.R.L. And Evvivax S.R.L.